GNLX - Genelux Corp
IEX Last Trade
2.14
0.160 7.477%
Share volume: 387,626
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.98
0.16
8.08%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-03-29 | 2024-05-09 | |
| Assets | ||||||
| Total Assets | 14.616 M | 31.363 M | 34.072 M | 27.893 M | 24.676 M | |
| Current Assets | 12.056 M | 28.683 M | 31.179 M | 24.203 M | 21.204 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 1.718 M | 1.543 M | 1.310 M | 1.012 M | 1.577 M | |
| Short Term Investments | 1.718 M | 1.543 M | 1.310 M | 1.012 M | 1.577 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 10.338 M | 27.140 M | 29.869 M | 23.191 M | 19.627 M | |
| Total Non-current Assets | 2.560 M | 2.680 M | 2.893 M | 3.690 M | 3.472 M | |
| Property Plant Equipment | 617.000 K | 878.000 K | 1.022 M | 1.170 M | 1.116 M | |
| Other Assets | 92.000 K | 92.000 K | 92.000 K | 92.000 K | 92.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 14.616 M | 31.363 M | 34.072 M | 27.893 M | 24.676 M | |
| Total liabilities | 11.925 M | 9.107 M | 10.044 M | 8.420 M | 9.592 M | |
| Total current liabilities | 10.543 M | 7.878 M | 8.755 M | 6.554 M | 7.805 M | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 1.665 M | 65.000 K | 40.000 K | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.691 M | 22.256 M | 24.028 M | 19.473 M | 15.084 M | |
| Common stock | 19.576 M | 25.068 M | 26.210 M | 26.863 M | 26.850 M | |
| Retained earnings | -203.591 M | -209.412 M | -214.757 M | -221.524 M | -229.374 M |